Skip to main content
. 2026 Jan 30;16(1):e110772. doi: 10.1136/bmjopen-2025-110772

Table 4. 6-month follow-up rate.

Variables Number of participants
N=3931
Primary follow-up outcomes capture rate, N (%)
 6-month mRS 3755 (95.6%)*
 6-month mRS, median (IQR) 1 (0–3)
 Stroke recurrence data captured with QVSFS 2144 (54.5%)
Data captured for patient-reported health outcomes N (%), N=3338
Patients alive and eligible for 6-month follow-up
 PROMIS-29 3080 (92.3%)
 Stroke Impact Scale version 3.0 (SIS-59) 3065 (92%)
 Barthel Index 3079 (92.2%)
 HADs 2744 (82%)
Follow-up methods, N (%) 3080
Face to face 1829 (59.4%)
Telephone 732 (23.8%)
Postal 392 (12.7%)
Proxy responder 127 (4.1%)
Detailed 6 months data (patients alive at 6-month N=1727) collection commenced 1 September 2018
 MOCA 1604 (93%)
 FMA 1506 (87%)
 TUG 1429 (83%)
 ART 796 (46%)
 SPD 872 (50.4%)
Added 5–10 years of outcomes commenced in September 2024
 Return to work and financial-resource strain
 Relationship status
 Sexual function

Table showing follow-up rate at 6-month post-stroke.

There is a small proportion of missing data in the NIHSS and thrombolysis variables.

*

Limited number of brain CT and MRI were conducted at a transferring centre.

ADL, Activities of Daily Living; ART, Aphasia Rapid Test; FMA, Fugl-Meyer Assessment of Motor Recovery; HADs, Hospital Anxiety and Depression scale; IADL, Instrumental Activities of Daily Living; MoCA, Montreal Cognitive Assessment; mRS, modified Rankin Scale; PROMIS-29, The Patient-Reported Outcomes Measurement and Information System-29; QVSFS, Questionnaire for Verifying Stroke-Free Status; SIS-59, Stroke Impact Scale-59; SPD, Spoken Picture Description; TUG, Timed-Up-and-Go.